Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance with Targeted Agents

Welcome and Pre-Seminar Prep: Setting Standards for HER2-Positive GI Cancers

Friday, July 1, 2022

13:40 – 13:55

Location: Rooms 111-112; Level 1

Session Chair(s)

Supported by Daiichi